baber/WOPTO huggingface dataset:
Patent JP-H0479887-B2 (JP)
IPC: B65B13/18
Filed: 1985-06-03
Abstract: PCT No. PCT/SE85/00232 Sec. 371 Date Feb. 4, 1986 Sec. 102(e) Date Feb. 4, 1986 PCT Filed Jun. 3, 1985 PCT Pub. No. WO86/00057 PCT Pub. Date Jan. 3, 1986.A method and a device for placing edge protecting means (7) at objects in connection with band strapping. The inventive method is distinguished in that blanks for edge protecting means (7) are fed as a continuous band (7a) which when advanced is preliminary bent around a longitudinal line, that the fed-out portion of the band (7a) is cut to form an edge protecting means (7) in correct position, and that the edge protecting means (7) is finally bent in connection with cutting. The inventive device is characterized in that a magazine containing blanks for edge protecting means in the form of a band (7a) is secured to a body (6) supporting a feeding mechanism (8-17) for said band which comprises means (8) for preliminary bending the band (7a) around a longitudinal line, a cutting means (30) being fixed to the body (6) serving to separate, after feeding the band a predetermined distance, the fed-out portion of the band as an edge protecting means (7), a bending means (30, 32) thereby being arranged to finally bend the edge protecting means (7) on separation thereof.
Patent JP-3287566-B2 (JP)
IPC: C08K5/17
Filed: 1992-07-09
Granted: 2002-06-04
Abstract: Stable aqueous dispersions of finely divided piperazine-containing polyamide resin particles and methods for the manufacture thereof are provided. Dispersions according to this invention find use in hot melt adhesives, coatings, inks, and the like.
Patent JP-S6318656-B2 (JP)
Inventor: PURANSHAN KUROODO
IPC: C22C/
Filed: 1983-10-04
Abstract: PCT No. PCT/FR83/00199 Sec. 371 Date Jun. 4, 1984 Sec. 102(e) Date Jun. 4, 1984 PCT Filed Oct. 4, 1983 PCT Pub. No. WO84/01390 PCT Pub. Date Apr. 12, 1984.The present invention relates to a process for the production of composite alloys based on aluminum, which may or may not be alloyed, and containing up to 30% by weight of boron. The process is characterized in that the boron is introduced into the liquid aluminum in the form of aluminum boride having the formula AlB2 or AlB12. It finds application in the production of composite alloys which are resistant to abrasion or which are intended to serve as neutron barriers in air or an aqueous medium.
Patent JP-3244698-B2 (JP)
IPC: H04N7/087
Filed: 1992-08-03
Granted: 2002-01-07
Abstract: Special data blocks or parts of data blocks are transmitted in redundant intervals or a heading is transmitted before the corresponding data block, after a suitable time interval, and another data block is inserted. By setting suitable bit errors or a parallel mode bit, premature interruption of data reeipt of the decoder is avoided. During transmission, teletext standared control bit for separating the type of magazine transmission is transmitted with the parallel mode code word.
Patent JP-H0358992-B2 (JP)
IPC: B65H29/00
Filed: 1984-09-19
Abstract: The winding mandrel comprises a cylindrical winding drum or body which has two circumferential web members on its inner side. Each web member lies substantially in a plane which lies outside the center of gravity of the winding mandrel together with the coil or wound package. The winding mandrel bears upon two driven and tandemly arranged support wheels with one of its web members. A support roll is arranged beneath these support wheels. A lateral support surface of the web member bears against this support roll. The support wheels are constructed as friction drive wheels and, in addition to supporting the winding mandrel, serve to drive the winding mandrel. Due to the overturning or tipping moment induced by the eccentricity of the bearing points of the winding mandrel upon the support wheels in relation to the center of gravity, the winding mandrel is pressed against the support roll. This has the effect that the winding mandrel maintains the desired position during its rotation. This position is partly determined by the support roll constituting a contact roll arranged to be immovable in the direction of the longitudinal axis of the winding mandrel.
Patent JP-3249520-B2 (JP)
IPC: A23B4/12
Filed: 1992-09-10
Granted: 2002-01-21
Abstract: PCT No. PCT/NL92/00156 Sec. 371 Date May 10, 1994 Sec. 102(e) Date May 10, 1994 PCT Filed Sep. 10, 1992 PCT Pub. No. WO93/04595 PCT Pub. Date Mar. 18, 1993A mixture of hydrogen peroxide and glycerol has been found to be a particularly effective composition as a preserving additive for raw materials, in particular foodstuffs. An organic acid, such as valeric acid, can be added to the mixture as stabiliser. By atomising the mixture, in combination with gentle shaking of the product to be treated in a device provided with means suitable for this purpose, an efficient treatment is effected with relatively low consumption of the preserving mixture. The shelf life of the products treated can be further increased by drying the surface thereof using sterile air.
Patent JP-2593132-B2 (JP)
IPC: H02P7/29
Filed: 1992-07-30
Granted: 1997-03-26
Abstract: The battery powered electrical device has an electrical load of essentially constant current consumption supplied via an electronic switch. A display shows the state of charge of the battery, and a time element determines the time for which the battery is connected to the load. After a defined battery-load connection time has elapsed and when the display is indicating a null charge state, the timing element isolates the load from the battery by means of the switch.
Patent JP-3567329-B2 (JP)
IPC: A61K9/00
Filed: 1992-12-05
Granted: 2004-09-22
Abstract: PCT No. PCT/EP92/02814 Sec. 371 Date Aug. 15, 1994 Sec. 102(e) Date Aug. 15, 1994 PCT Filed Dec. 12, 1992 PCT Pub. No. WO93/11746 PCT Pub. Date Jun. 24, 1993.In order to control and optimize the amount of inhalable active substance released when drugs are administered as inhalation powders, the invention calls for the use of auxiliaries consisting of mixtures of coarser particles (average particle size>20  mu m) and finer particles (average particle size<10  mu m).
Patent JP-3889808-B2 (JP)
IPC: A61K48/00
Filed: 1995-10-03
Granted: 2007-03-07
Abstract: A strain of hepatitis E virus from Pakistan (SAR-55) implicated in an epidemic of enterically transmitted non-A, non-B hepatitis, now called hepatitis E, is disclosed. The invention relates to the expression of the whole structural region of SAR-55, designated open reading frame 2 (ORF-2), in a eukaryotic expression system. The expressed protein is capable of forming HEV virus-like particles which can serve as an antigen in diagnostic immunoassays and as an immunogen or vaccine to protect against infection by hepatitis E.
Patent JP-2870704-B2 (JP)
IPC: G01N33/542
Filed: 1993-01-22
Granted: 1999-03-17
Abstract: There is provided a method for assaying homocysteine in a sample, e.g. blood, plasma or urine, which comprises the steps of contacting said sample with a homocysteine converting enzyme other than SAH-hydrolase and at least one substrate for said enzyme other than homocysteine, and without chromatographic separation assessing a non-labelled analyte selected from a homocysteine co-substrate and the homocysteine conversion products of the enzymic conversion of homocysteine by said enzyme.
Patent JP-3425957-B2 (JP)
IPC: A61B18/12
Filed: 1996-10-02
Granted: 2003-07-14
Abstract: An electrocautery device is disclosed. In accordance with one aspect of the invention, the electrocautery electrode/tip is provided with a hollow, conductive tube terminating at its distal end in a ball point type tip. Fluid, preferably conductive fluid, is applied to the proximal end of the hollow electrode/tip, and expelled from the distal end thereof during electrocautery. The conductive fluid is supplied by a pressurized canister. The ball point distal tip allows the distal tip to be directly applied to the tissue and "rolled" or slid along the tissue. This allows the distal tip to be moved across the tissue without dragging or snagging on the tissue. In addition, the conductive fluid expelled from the distal tip further lubricates the distal tip as it moves across the tissue. If conductive fluid is used, the conductive fluid emanating from the electrode/tip conducts the RF electrocautery energy away from the distal tip so that it is primarily the fluid, rather than the distal tip that actually accomplishes the cauterizing of tissue. That is, the fluid serves as a "virtual" electrocautery electrode. Since it is the fluid, rather than the distal tip that cauterizes, coagulates and ablates, no burns or perforations are made to the tissue, reducing the amount of debris at the site. Also, the flow of fluid through the electrode/tip tends to keep the distal tip clean and cool. <IMAGE>
Patent JP-3961026-B2 (JP)
IPC: C12N15/82
Filed: 1996-12-27
Granted: 2007-08-15
Abstract: A method for producing temperature-tolerant plants, which comprises transforming a plant with a recombinant vector carrying a gene encoding choline oxidase, as well as temperature-tolerant plants produced by said method or progenies thereof having the same properties.
Patent JP-3043424-B2 (JP)
IPC: F23N5/08
Filed: 1996-02-29
Granted: 2000-05-22
Abstract: The invention concerns a process for regulating the combustion in a steam-generation facility, in which the three-dimensional temperature distribution and concentration profile of at least one reaction product created in the combustion process are determined. In the proposed process, in order to ensure even steam generation with high efficiency and low emission of harmful pollutants, a number of reference values (SWn) for the composition of the reaction mixture (B, L, H) to be fed into the combustion process are determined by fuzzy or neuro-fuzzy logic using the temperature distribution and concentration profile. A device for carrying out the process is provided with at least two optical sensors (2, 3) for picking up radiation data (D) from a combustion chamber (1) and, connected to the sensors, a data processing system (4) which is connected to a control unit (6) provided with a fuzzy or neuro-fuzzy regulator component (5).
Patent JP-4053092-B2 (JP)
IPC: G01N33/76
Filed: 1998-01-30
Granted: 2008-02-27
Abstract: The present invention relates to a method for at least one of detecting, quantifying or isolating at least one analyte from a liquid medium in which the analyte is distributed and comprises providing a reagent comprised of particles having a receptor for an analyte fixed to the particles distributed in the medium and a capturing means having an exposed surface defining an active zone. An intermediate reagent is formed by the complex of the reagent with the analyte. A second receptor is fixed in the active zone to capture either the analyte bound by the reagent or the receptor (capture partners). The active zone serves as a site of isolation and concentration of the capture partners.
Patent ES-2320085-B2 (ES)
Title: Metodo para el marcaje e identificacion de objetos manufacturados, sustancias y organismos, y sus usos.
Inventor: GARCIA ALONSO JOSE IGNACIO
IPC: G01N33/02
Filed: 2009-02-13
Granted: 2010-03-09
Abstract: Método para el marcaje e identificación de
objetos manufacturados, sustancias  y organismos, y sus usos. La
presente invención comprende un método de  marcaje e identificación
de objetos manufacturados, sustancias y organismos  (en adelante
"productos") basado en la adición al producto a marcar de  una
mezcla conocida de dos o más perfiles isotópicos de un mismo
elemento  químico enriquecidos en distintos isótopos estables. La
medida de la relación  de fracciones molares entre esos perfiles
isotópicos presentes en el producto  mediante Espectrometría de
Masas permite su identificación. También es  objeto de la presente
invención el uso del producto marcado según el método  anterior para
marcar otros productos derivados del mismo, o que lo utilizan  en su
composición. La presente invención resulta de aplicación en el
marcaje  encubierto de objetos manufacturados, sustancias y
organismos en los sectores  farmacéutico, de explosivos, joyas,
obras de arte, plantas, alimentos y  drogas de abuso, entre
otros.
Patent ES-2592821-B2 (ES)
Title: Gafas multiuso de lentes intercambiables
Inventor: CLAVERIAS TORRES PEDRO
IPC: G02C1/08
Filed: 2016-06-30
Granted: 2017-06-21
Abstract: Gafas multiuso de lentes intercambiables; que comprenden: una montura (1) provista de dos marcos (11) para el montaje de unas lentes y de unas patillas (12) de sujeción; y unas parejas de lentes intercambiables (2, 2a) con diferentes características (color, protección solar, graduación, resistencia, polarización), provistas en su contorno de al menos una porción ferromagnética (21), dispuesta en una posición predeterminada y adecuada para enfrentarse con unos imanes (13) fijados en el contorno interior de los marcos (11) y que conforman unos medios de sujeción liberable de las lentes intercambiables (2, 2a) a la montura (1). Las patillas (12) laterales presentan en una zona proximal de mayor anchura sendas cavidades (15) para el alojamiento de al menos una pareja de lentes intercambiables (2, 2a) de recambio.
Patent AU-2001227466-B2 (AU)
Title: Method of treating a meat processing plant waste stream
Inventor: BARLOW STACEY L
IPC: A23L13/30
Filed: 2000-10-20
Granted: 2005-11-03
Abstract: A method of treating an organic waste stream, such as the waste from a meat processing plant, to substantially remove solid organic matter from the stream. The method substitutes MgCl2 and small amounts of AlCl3 for the FeCl3 that was used in the prior art process, before adding polymeric flocculents. The polymeric flocculents are added as they are in the prior art, and the solid precipitate is removed by physical separation.
Patent AU-2001240982-B2 (AU)
Title: Method for diagnosing efficacy of xenotypic antibody therapy
Inventor: NOUJAIM ANTOINE
IPC: G01N33/68
Filed: 2001-02-08
Granted: 2006-05-04
Abstract: The invention provides methods for diagnosing the efficacy of a patient to xenotypic antibody therapy which include (1) measuring the level of an antibody produced by a patient that specifically binds to a a xenotypic antibody after administration of the xenotypic antibody to the patient; (2) measuring the level of an anti-idiotype antibody produced by a patient that specifically binds to a a xenotypic antibody after administration of the xenotypic antibody to the patient; (3) measuring the level of an antibody produced by a patient that specifically binds to a target antigen of a xenotypic antibody after administration of a xenotypic antibody to the patient; and (4) measuring the level of a T cell response produced by a patient to a target antigen of the xenotypic antibody after administration of a xenotypic antibody to the patient. In the methods of the invention, an increase in the level of antibody or T cell response produced by the patient after the administration of the xenotypic antibody relative to the level antibody or T cell response produced by the patient prior to the administration of the xenotypic antibody is indicative of a favorable diagnosis of efficacy.
Patent AU-2001290784-B2 (AU)
Title: Antimicrobial peptides and methods of use
Inventor: ACEVEDO PEDRO A NAVARRO
IPC: C12Q1/68
Filed: 2001-09-13
Granted: 2006-02-16
Abstract: The invention provides isolated KCP-like nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering KCP-like nucleic acid and/or protein concentration and/or composition of plants. The invention further provides recombinant expression cassettes, host cells, and transgenic plants.
Patent AU-2002218740-B2 (AU)
Title: Microarray method of genotyping multiple samples at multiple loci
Inventor: SCHENA MARK A
IPC: C12Q1/68
Filed: 2001-07-03
Granted: 2007-03-22
Abstract: A method for genotyping multiple samples at multiple genetic loci in a single assay is provided. Microarrays of genomic segments representing discrete loci are formed and hybridized with mixtures of synthetic oligonucleotides that are complementary to the genomic segments. Genotyping information is derived by reading the microarray signals. The method can be used to characterize samples from diverse biological sources and for a variety of applications.
Patent AU-2002235682-B2 (AU)
Title: Thiophene substituted amine derivatives as GLYT-1 inhibitors
Inventor: HOPPER ALLEN T
IPC: C07D333/22
Filed: 2002-02-15
Granted: 2007-04-26
Abstract: The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula:or a pharmaceutically acceptable salt thereof.
Patent AU-2003256858-B2 (AU)
Title: Use of biomarkers for detecting ovarian cancer
Inventor: MENG XIAO-YING
IPC: C12Q1/25
Filed: 2003-08-05
Granted: 2010-07-01
Abstract: The present invention relates to a method of qualifying ovarian cancer status in a subject comprising: (a) measuring at least one biomarker in a sample from the subject and (b) correlating the measurement with ovarian cancer status. The invention further relates to kits for qualifying ovarian cancer status in a subject.
Patent AU-2004227832-B2 (AU)
Title: Apparatus and method for supporting vertebral bodies
Inventor: BARKER B THOMPSON
IPC: A61B17/02
Filed: 2004-03-31
Granted: 2010-07-08
Abstract: An apparatus and method for supporting upper and lower vertebral bodies, including first and second end members adapted for engagement with the vertebral bodies, and at least one elongate support member coupled between the end members to maintain an axial space between the vertebral bodies. In one aspect of the invention, each of the end members has a parametrical or horseshoe-shaped configuration extending about an open inner region and defining a lateral passage communicating with the open inner region to facilitate insertion of the apparatus or the individual end members into the intervertebral space via a posterior surgical approach. In a further aspect of the invention, a fusion member is positioned within the axial space to promote bony fusion between the upper and lower vertebral bodies.
Patent AU-2005252110-B2 (AU)
Title: 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-D] pyrimidine derivatives and related compounds for the treatment of cancer
Inventor: IIDA TETSUYA
IPC: C07D487/04
Filed: 2005-06-10
Granted: 2008-09-04
Abstract: The present invention relates to a pyrimidine compound represented by the following formula [I]   
wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a pharmaceutical agent for the prophylaxis or treatment of a disease caused by undesirable cell proliferation, particularly an antitumor agent, which contains such compound. The compound of the present invention has superior undesirable cell proliferation suppressing action, particularly, an antitumor action, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, antirheumatoid agent and the like. In addition, by the combined use with other antitumor agent such as alkylating agent, metabolism antagonist and the like, it can be a more effective antitumor agent.
Patent AU-2005287876-B2 (AU)
Title: Compression garments and a method of manufacture
Inventor: THOMAS DUFFY BRADLEY
IPC: A41D27/24
Filed: 2005-09-23
Granted: 2011-12-01
Abstract: The invention provides a compression garment (50) for clothing a body part, such as a lower torso and the legs. The body part includes a muscle ridge, such as a lateral edge of the gluteus maximus (49). Compression garment (50) has first and second panels of stretchable material joined by a seam (32). At least part of the seam (32) is adapted to correspond to at least part of the muscle ridge, being at the edge of the gluteus maximus (49). The invention also provides a method of manufacturing a compression garment, using an algorithm to calculate size changes to produce desired compression.
Patent AU-2005310118-B2 (AU)
Title: Dielectric fluids and processes for making same
Inventor: ROSENBAUM JOHN M
IPC: C10M101/00
Filed: 2005-11-21
Granted: 2011-09-15
Abstract: Dielectric fluids comprising oil fractions derived from highly paraffinic wax are provided. Further provided are processes for making these dielectric fluids comprising oil fractions derived from highly paraffinic wax. The dielectric fluids are useful as insulating and cooling mediums in new and existing power and distribution electrical apparatus, such as transformers, regulators, circuit breakers, switchgear, underground electrical cables, and attendant equipment.
Patent AU-2006222766-B2 (AU)
Title: Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
Inventor: WOLF CHARLES ROLAND
IPC: A23L33/00
Filed: 2006-09-29
Granted: 2009-08-06
Abstract: The molecules of formula (1) are useful in treating diabetes, obesity, hypercholesterolaemia, hyperlipidaemia, cancer, inflammation of other conditions in which modulation of lipid or eicosanoid status or functions may be desirable. Formula (1): Z 1 -X-Z 2  wherein (a) Z 1  represents CO 2 H or a derivative thereof; (b) Z 2  represents F, H, -CO 2 H or a derivative thereof; and (c) X represents fluorinated alkylene; or a solvate thereof, for example a perfluorinated fatty acid or derivative thereof.
Patent AU-2006259585-B2 (AU)
Title: Modifiers for gypsum slurries and method of using them
Inventor: BLACKBURN DAVID R
IPC: C04B11/00
Filed: 2006-06-13
Granted: 2011-07-14
Abstract: An improved gypsum slurry that includes water, calcium sulfate hemihydrate, a polycarboxylate dispersant and a modifier. The modifier is chemically configured to improve the efficacy of the polycarboxylate dispersant. Preferred modifiers include cement, lime, slaked lime, soda ash, carbonates, silicates and phosphates.
Patent AU-2006270501-B2 (AU)
Title: Synergistic composition and method for inhibiting growth of microorganisms
Inventor: SIMONS BERT
IPC: C07D487/10
Filed: 2006-05-09
Granted: 2012-02-09
Abstract: The present invention provides a composition and method for inhibiting the growth of microorganisms in industrial water systems. Methods employing the composition comprising halogen-based hydantoin or hydantoin-stabilized halogen in combination with peracetic acid demonstrate synergistic control of microbial growth, particularly control of slime deposition.
Patent AU-2006290896-B2 (AU)
Title: Roller trainer assembly
Inventor: PAPADOPOLOUS LARRY C
IPC: A63B69/16
Filed: 2006-09-14
Granted: 2012-02-02
Abstract: A bicycle exercise assembly (10) adapted to be mounted on a supporting surface includes a bicycle trainer device (12), adapted to operatively support an exercising person. Also, a relative motion-permitting assembly (16, 20, 24) is adapted to be supported by the surface and to support the bicycle trainer device and to permit relative motion between the bicycle trainer device and the surface.
Patent AU-2006315284-B2 (AU)
Title: Random copolymer compositions for treating unwanted immune response
Inventor: BONNIN DUSTAN
IPC: A61P37/00
Filed: 2006-11-17
Granted: 2013-02-07
Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers. The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.